share_log

Cantor Fitzgerald Reiterates Overweight on Structure Therapeutics, Maintains $65 Price Target

Moomoo 24/7 ·  Apr 18 09:53

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $65 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment